Brain cancer drugs approved in England

Apr 11, 2007

England's National Institute for Health and Clinical Excellence has removed a ban on two drugs that may help patients with rare life-threatening brain cancer.

Temodal and Gliadel may now be obtained through the National Health Service. The 2005 ban was based on cost-effectiveness.

The Times of London says the ban caused anger because Temodal was actually invented by British scientists with funding from Cancer Research UK.

Gliadel is a wafer that, when placed at the site where a brain tumor was removed, clears remaining cancer cells and keeps the tumor from recurring, the newspaper said.

Both drugs have been available in the United States and Canada.

Ella Pybus, spokeswoman for a consortium of cancer charities, said, "Everyone is relieved."

She said there is "solid evidence" the drugs help patients.

Copyright 2007 by United Press International

Explore further: Xtoro approved for swimmer's ear

add to favorites email to friend print save as pdf

Related Stories

Climate change could leave cities more in the dark

19 minutes ago

Cities like Miami are all too familiar with hurricane-related power outages. But a Johns Hopkins University analysis finds climate change will give other major metro areas a lot to worry about in future storms.

Mathematicians prove the Umbral Moonshine Conjecture

19 minutes ago

Monstrous moonshine, a quirky pattern of the monster group in theoretical math, has a shadow - umbral moonshine. Mathematicians have now proved this insight, known as the Umbral Moonshine Conjecture, offering ...

How electrons split: New evidence of exotic behaviors

25 minutes ago

Electrons may be seen as small magnets that also carry a negative electrical charge. On a fundamental level, these two properties are indivisible. However, in certain materials where the electrons are constrained in a quasi ...

Recommended for you

Xtoro approved for swimmer's ear

17 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

17 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.